R. Tian, Y. Guo, X. Zhang, X. Zhang, and X. Song, “Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance”, Pak J Med Sci, vol. 40, no. 8, Jul. 2024.